First thyroid eye disease drug inches closer to approval
- Posted on: Dec 16 2019
- Leave a response
An FDA advisory committee unanimously backed teprotumumab as the first nonsurgical treatment for thyroid eye disease, according to a press release by Horizon Therapeutics.
Source: AAO
Posted in: Uncategorized
